Published in Eur J Dent on July 01, 2009
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Cutaneous wound healing. N Engl J Med (1999) 19.12
Wound healing--aiming for perfect skin regeneration. Science (1997) 16.08
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A (2000) 11.41
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci (2006) 8.09
Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A (2001) 7.19
SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A (2003) 6.80
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy (2005) 5.92
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007) 5.83
A fresh look at iPS cells. Cell (2009) 5.73
Regenerating the heart. Nat Biotechnol (2005) 5.58
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol (2003) 5.35
Why are MSCs therapeutic? New data: new insight. J Pathol (2009) 5.25
Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials (2006) 5.22
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med (2006) 4.53
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol (2005) 4.27
Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood (2003) 4.09
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood (2004) 4.04
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A (2002) 4.03
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol (2007) 3.87
Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci U S A (2009) 3.73
Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol (2001) 3.04
Potential risks of bone marrow cell transplantation into infarcted hearts. Blood (2007) 2.97
Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci (2001) 2.84
Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest (2003) 2.81
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int (2007) 2.75
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
Stem cells in tissue engineering. Nature (2001) 2.62
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells (2008) 2.51
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation (2003) 2.49
Immunoregulatory function of mesenchymal stem cells. Eur J Immunol (2006) 2.47
Alternatives to Autogenous Bone Graft: Efficacy and Indications. J Am Acad Orthop Surg (1995) 2.46
Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells (2008) 2.42
Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum (2002) 2.20
Mesenchymal stem cells: progress toward promise. Cytotherapy (2005) 2.19
Immune modulation by mesenchymal stem cells. Exp Cell Res (2006) 1.99
The efficacy of mesenchymal stem cells to regenerate and repair dental structures. Orthod Craniofac Res (2005) 1.97
The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering. J Endod (2008) 1.95
Wnt signaling controls the fate of mesenchymal stem cells. Gene (2008) 1.92
Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica (2008) 1.87
Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int (2006) 1.82
Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) (2004) 1.82
Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb (2006) 1.78
A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int (2002) 1.69
Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.67
Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells (2006) 1.63
Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. J Bone Miner Res (2003) 1.51
Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol (2007) 1.46
Dentin regeneration by dental pulp stem cell therapy with recombinant human bone morphogenetic protein 2. J Dent Res (2004) 1.46
Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun (2004) 1.43
The mesenchymal stromal cell contribution to homeostasis. J Cell Physiol (2008) 1.42
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci (2004) 1.33
Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng (2008) 1.31
Methodology, biology and clinical applications of mesenchymal stem cells. Front Biosci (Landmark Ed) (2009) 1.31
Expression of mineralization markers in dental pulp cells. J Endod (2007) 1.29
Odontoblasts: the cells forming and maintaining dentine. Int J Biochem Cell Biol (2004) 1.27
Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res (2006) 1.21
The vascular wall as a source of stem cells. Ann N Y Acad Sci (2005) 1.20
Odontogenic capability: bone marrow stromal stem cells versus dental pulp stem cells. Biol Cell (2007) 1.18
Stem cell transplantation for neurodegenerative diseases. Curr Opin Neurol (2007) 1.17
Human stem cells for CNS repair. Cell Tissue Res (2007) 1.15
Regeneration of teeth using stem cell-based tissue engineering. Expert Opin Biol Ther (2006) 1.13
Advancing cartilage tissue engineering: the application of stem cell technology. Curr Opin Biotechnol (2005) 1.13
Differentiation of dental pulp stem cells into regular-shaped dentin-pulp complex induced by tooth germ cell conditioned medium. Tissue Eng (2006) 1.13
Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc Pathol (2005) 1.11
Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev (2007) 1.10
The new stem cell biology: something for everyone. Mol Pathol (2003) 1.10
Diabetic foot infections: stepwise medical and surgical management. Int Wound J (2004) 1.10
Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun (2003) 1.07
The impact of periodontal infection on systemic diseases. Med Sci Monit (2003) 1.05
Tissue-engineered skin containing mesenchymal stem cells improves burn wounds. Artif Organs (2008) 1.03
Bone marrow cells can give rise to ameloblast-like cells. J Dent Res (2006) 1.03
Dental pulp stem cells. Methods Enzymol (2006) 1.02
Parallels between tooth development and repair: conserved molecular mechanisms following carious and dental injury. J Dent Res (2004) 1.01
Bioengineered dental tissues grown in the rat jaw. J Dent Res (2008) 1.01
The diabetic foot. Surg Clin North Am (2007) 0.98
Restorative pulpal and repair responses. J Am Dent Assoc (2001) 0.96
Bone marrow stromal stem cells for tissue engineering. Periodontol 2000 (2006) 0.93
Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Transplant (2003) 0.92
Biological tooth replacement and repair. J Oral Rehabil (2007) 0.88
In vivo evaluation of human dental pulp stem cells differentiated towards multiple lineages. J Tissue Eng Regen Med (2008) 0.87
Heart failure: recent advances in prevention and treatment. Rev Cardiovasc Med (2000) 0.84
Current approaches and challenges in making a bio-tooth. Tissue Eng Part B Rev (2008) 0.83
The use of stem cells for the treatment of autoimmune diseases. Braz J Med Biol Res (2007) 0.83
Therapeutic potentials of stem cells in cardiac diseases. Minerva Cardioangiol (2009) 0.81
Mesenchymal stem cell therapy for degenerative inflammatory disorders. Curr Opin Organ Transplant (2008) 0.79
Distant microglial and astroglial activation secondary to experimental spinal cord lesion. Arq Neuropsiquiatr (2001) 0.79
Physiology of microglia. Physiol Rev (2011) 6.99
CD38 is critical for social behaviour by regulating oxytocin secretion. Nature (2007) 2.44
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet (2003) 2.24
Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci (2007) 1.74
Inter-regional contribution of enhanced activity of the primary somatosensory cortex to the anterior cingulate cortex accelerates chronic pain behavior. J Neurosci (2011) 1.67
Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. PLoS One (2009) 1.46
Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res (2010) 1.35
Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin Exp Metastasis (2010) 1.26
Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem Biophys Res Commun (2003) 1.07
Developmental regulation of ubiquitin C-terminal hydrolase isozyme expression during spermatogenesis in mice. Biol Reprod (2004) 1.01
Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo. Am J Pathol (2004) 1.01
Two closely related ubiquitin C-terminal hydrolase isozymes function as reciprocal modulators of germ cell apoptosis in cryptorchid testis. Am J Pathol (2004) 0.99
Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes. Oxid Med Cell Longev (2012) 0.98
Overexpression of ubiquitin carboxyl-terminal hydrolase L1 arrests spermatogenesis in transgenic mice. Mol Reprod Dev (2006) 0.97
Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J Cell Sci (2006) 0.96
Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem Int (2006) 0.96
Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia (2011) 0.94
Photoreceptor cell apoptosis in the retinal degeneration of Uchl3-deficient mice. Am J Pathol (2006) 0.91
Accumulation of beta- and gamma-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse. Brain Res (2004) 0.89
Protein kinase C bound with A-kinase anchoring protein is involved in muscarinic receptor-activated modulation of M-type KCNQ potassium channels. Neurosci Res (2005) 0.89
Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice. J Neuroinflammation (2012) 0.88
A kavalactone derivative inhibits lipopolysaccharide-stimulated iNOS induction and NO production through activation of Nrf2 signaling in BV2 microglial cells. Pharmacol Res (2013) 0.87
Effects of plasmalogens on systemic lipopolysaccharide-induced glial activation and β-amyloid accumulation in adult mice. Ann N Y Acad Sci (2012) 0.86
Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses. Brain Res Mol Brain Res (2005) 0.86
Induction of interleukin-1β by activated microglia is a prerequisite for immunologically induced fatigue. Eur J Neurosci (2014) 0.86
Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. Glia (2004) 0.85
Oral 'hydrogen water' induces neuroprotective ghrelin secretion in mice. Sci Rep (2013) 0.85
Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight. Neuromolecular Med (2013) 0.83
Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochem Int (2007) 0.83
Parkin potentiates ATP-induced currents due to activation of P2X receptors in PC12 cells. J Cell Physiol (2006) 0.82
Measurement of adenylyl cyclase by separating cyclic AMP on silica gel thin-layer chromatography. Anal Biochem (2002) 0.82
Subtype-specific coupling with ADP-ribosyl cyclase of metabotropic glutamate receptors in retina, cervical superior ganglion and NG108-15 cells. J Neurochem (2003) 0.81
Translocation of glutamate transporter subtype excitatory amino acid carrier 1 protein in kainic acid-induced rat epilepsy. Am J Pathol (2003) 0.81
The effect of zinc on glycinergic inhibitory postsynaptic currents in rat spinal dorsal horn neurons. Brain Res (2007) 0.80
Sodium fluxes and astroglial function. Adv Exp Med Biol (2013) 0.79
Identification of a novel regulatory mechanism for norepinephrine transporter activity by the IP3 receptor. Eur J Pharmacol (2006) 0.79
Therapeutic effects of hydrogen in animal models of Parkinson's disease. Parkinsons Dis (2011) 0.79
Effects of chemokine (C-C motif) ligand 1 on microglial function. Biochem Biophys Res Commun (2013) 0.79
Modulation of ATP-induced inward currents by docosahexaenoic acid and other fatty acids in rat nodose ganglion neurons. J Pharmacol Sci (2006) 0.78
Overexpression of human CD38/ADP-ribosyl cyclase enhances acetylcholine-induced Ca2+ signalling in rodent NG108-15 neuroblastoma cells. Neurosci Res (2006) 0.78
Facilitation of spontaneous glutamate release by antidepressant drugs in rat locus coeruleus. Neurosci Lett (2005) 0.78
Heightened amygdala long-term potentiation in neurotensin receptor type-1 knockout mice. Neuropsychopharmacology (2008) 0.76
Effects of 3,3',5-triiodothyronine on microglial functions. Glia (2015) 0.76
Potentiation of ATP-induced currents due to the activation of P2X receptors by ubiquitin carboxy-terminal hydrolase L1. J Neurochem (2005) 0.76
Inhibition of the serotonin-induced inward current by dextromethorphan in rat nodose ganglion neurons. Brain Res (2006) 0.75
Bradykinin activates ADP-ribosyl cyclase in neuroblastoma cells: intracellular concentration decrease in NAD and increase in cyclic ADP-ribose. FEBS Lett (2006) 0.75
Functional importance of inositol-1,4,5-triphosphate-induced intracellular Ca2+ mobilization in galanin-induced microglial migration. J Neurochem (2011) 0.75
Architecture and design of non-drug therapy for reactive oxygen spcecies (ROS)-induced diseases. Curr Pharm Des (2011) 0.75